NURS 350 - Pathophysiology (PDF)

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Summary

This document provides an overview of infection, stress, disease, and cancer from a biological perspective. It details the factors that influence infections, including communicability, infectivity, and virulence. The text covers the process of infection, stages of infection, and different types of infections, including endemic, epidemic, and pandemic.

Full Transcript

it keek 5 : Infection , Stress & Disease , Cancer...

it keek 5 : Infection , Stress & Disease , Cancer Biology Chapter 70 : Infection Infection is the invasion and multiplication of microorganisms in the body tissues that cause disease => For it must infection to occur, interfere with a person , pathogen, and. environment => disease death and due to infectious significant morbidity : causes - Emergence of infections. new · Reumergence of unknown infections. · · Development of antibiotic resistant infections - * most deaths related to infections are found in immunocompromised people (children , elderly , chronic illnesses). Microrganism and Humans survival Body · can compatible for pathogens be Mutual symbiotic relationship · · Normal microbiome - Resident microorganisms are found in diff-parts of the body. - Produces enzymes that help digestion. Produces antibacterial factors - - Produces metabolites (vitamin K and B vitamins) Factors for Infection D Communicability-ability to spread disease from to others one. 2) Infectivity-ability of pathogen to invade and multiply in host - 3) virulence Capacity - pathogen to cause severe disease of. # Pathogenicity Ability of an agent to produce disease. - 5 Portal of entry-route by which pathogenic microorganism infects host. 6) Toxigenicity Ability to produce soluble toxins or endotoxins factors - , that influence pathogen's virulence. Process ofInfection a. Transmission-infections microorganisms are transmitted by (direct indirect droplet/airborne vertical/hor-trans) , , , Colonization 6 - Ability of pathogen to survive and multiply - or on within the human - environment c Invasion Invades surrounding tissues by evading host's defenses.. - d Dissemination. - Spread of infection by direct extension through surrounding tissue , blood , or lymphatic vessels e. Cell/Tissue damage - may occur directly by lysis or toxin prod. by an immune response. - Tissue damage enhances pathogenicity of the organism. Stages of Infection Incubation - period from initial exposure to onset of first symptoms. Prodromal - occurence of initial symptoms usually mild (discomfort tired) Famil , Invasion-mores and body tissues. farther affects other and Convalescence recovery occurs symptoms decline or the disease - , is fatal , or has a period of latency. infectious to others. * Infection is usually dependent on adequate numbers of microorganisms the host's rather than a compromise of defenses. Classification of Infections · Infections disease is spread from person to person · Endemic relatively high but constant rates of infection Diseases with , , in particular population a. Epidemic · Number of new infections in particular population that greatly a exceeds the number usually observed. · Pandemic An that epidemic spreads over a large area such as a continent or worldwide. Pathogenic Defense Mechanism disease by pathogens successfully cause : - a. Compete with normal flora b. Produce toxins Produce enzymes c to avoid phagocytosis opsonization destroy , , connective tissues d Avoid lysis-stop complement cascade by degrading 236. e Paralyze ciliary activity. Produce f biofilms to protect from immune cells/antibiotics.. BACTERIAL INFECTION - Bacteria is prokaryotic , ine no discreet nucleus. Important factors in infection include helping bacteria cause - - : Fron needed to multiply (siderophores iron receptors) · - presence of polysaccharide capsules · Suppression of complement activation · Bacterial rates proliferation surpassing protective response · => Bacteremia (presence) or Septicemia (growth) * Sepsis can lead to shock and vascular compromise. · Bacteria present in blood bacteria-releases toxins Gram-negative · * Endotoxins LPS found in cell wall bacteria, or of gram-neg released when bacteria cell wall is lysed. · Failure of the body's defense mechanism. · Endotoxins released in blood activate complement and clotting systems- ↳ capillary permeability causes plasma to escape into surrounding tissues producing widespread hypotension ; severe cases= cardiovascular shock. · staphylococcus aureus nosocomial major causes of hospital or infection life threatening - , common on skin and nasal passages. - - opportunistic , secretes endotoxins - Antibiotic resistance is a major problem. Toxin production · A) Exotoxins Creleased microbe) from living Enzymes that damage host cell plasma membranes or can · inactivate critical to protein synthesis. enzymes B) Endotoxins Creleased LPS) from lysed gram-negative bacteria : Activate inflammatory response and produce fever. · · GRAM-NEGATIVE BACTERIA - Do not retain crystal violet dye in Gram staining process. Thin LPsCendotoxin), peptidoglycan layer and outer membrane with - phospholipids proteins , · GRAM-POSITIVE BACTERIA Retains crystal violet dye in staining - gram process. and Thick peptidoglycan layer with reichoic lipoteichoic - acids. LPS Effects : - Low Quantities - monocyte activation endothelial cell , activation activation , complement Crocal inflammation) Moderate Quantities - Fever (Brain) , Acute-phase reactant CLiver) , Leucocytes (Bone) (systemic Effects High Quantities : - Low cardiac output and peripheral resistance , blood vessel ARDS injury , [Septic shock) CLINICAL MANIFESTATIONS OF INFECTIONS DISEASE - Variable, depends on pathogen · caused directly by pathogen , or indirectly by its products · Fatigue , malaise , weakness , loss of concentration , generalized aching loss of appetite ,. - Fever Hallmark of infection · Exogenous pyrogens-outside of host · Endogenous pyrogens-made by host inflammatory response. · COUNTERMEASURES AGAINST BACTERIAL PATHOGENS · Antibiotic resistance Horizontal gene transfer · inactivation Enzymatic antibiotics · of · Aminoglycoside-modifying enzymes CAmEs) Multi-drug resistant transporters (MDRs) · - Proteins that prevent antibiotic cell access Target bypass Cresistance mechanism) · => Methicillin-resistant Staphylococcusaureus (MRSA) - International health crisis overuse of antibiotics/not completing antibiotic regimen - - Fusidic acid : binds to ribosome and prevents proton synthesis old treatment revisited : bacteriophages - viruses that infect bacteria. - - Produces beta lactamase FUNGAL INFECTIONS - Large microorganisms with thick , rigid cell walls - Mold yeast dimorphic , , - Eukaryotic - Disease caused by fungi : Mycosis - Transmitted by inhalation or contamination of wounds. - Dermatophytes if infection invade skin hair or nails , , - Systemic infection is usually from immunosuppression - Pneumocystis Carinic was reclassified as fungus and named a P. jirorecii - Adapt to host environment (wide temp variations, low. oxygen , MptD - suppress immune defenses => Candida albicans - most common fungal infection - found on skin, GI tract , mouth , raging - Local defense mechanisms and microbiome produce antifungal agents - Remains localized of : Immune is intact system · · Immune system is compromised , then infection can become systemic. PARASITIC AND PROTOLOAN INFECTIONS Parasitic => infections · Toxoplasma gondii Trichomonas Vaginalis · => Protozoan Infections Transmitted through rectors : - · Malaria by mosquitoes Trypanosomes by fly tsetse · Leishmania spp by sand flies · - contaminated water food Cardia lambia) Others found in · or VIRAL INFECTIONS Most - common afflictions of humans - Viruses are intracellular parasites ; replication depends on ability host cell. to infect - self-limiting. Do not have any metabolic organelles necessary for reproduction - · Replicates by taking over the metabolic systems of host cell May Kill cell, coexist with cell be killed or by immune · , system. - Transmission : aerosol , infected blood sexual contact rector- , , - rarely produce Viruses toxins Viral infection symptoms are mild (ever aches nausea - , , , hantavines Some viruses rapidly proliferate (norovirus rotorious ebola marburg, - , , , Interferons effective against many viruses are - - Viruses are sensitive to complement activation. Life Cycle of Viruses : - completely intracellular · Translation of mRNA results in the production of viral proteins. budding For enveloped viruses , virious released through. · new are host cell and transmitted Viral DNA is integrated in the to · daughter cells by mitosis. => Harmful Effects Viruses of · Inhibition DNA RNA or protein synthesis of , Disruption lysosomal membranes · of Promotion of cell apoptosis · Fusion of adjacent cells (giant cells) · Transformation into cancer cells · cells) Alteration of antigenic properties Cimmune attacks normal · => Stages of Viral Infection · Attach to host cell via protein receptors · Penetrates host cell · releases genetic information into host cytoplasm uncoating - - RNA viruses enter host nucleus - produce mRNA HIV may produce provirus DNA Cretoviruses - : - DNA viruses enter host nucleus - may integrate into host DNA or may make mRNA - => Viral Replication Translationof mRNA results in the production of viral proteins. · Assembly of new virions are released through budding. · · Viral DNA is integrated in host cell - DNA is transmitted to daughter cells by mitosis. # IV and AIDS AIDS caused viral HIV is by · Depletes the helper (Th) cells body's T - HIV is a form of secondary immunodeficiency. - is susceptible to life-threatening infections and - cancer. - Incidence : ↳ Worldwide : is and remains and a major cause of morbidity mortality ; Africa is the epicenter of the AIDS pandemic - - At the end 2020 estimated 37 7 million living with HIV of. , globally- ↳ United States : - 1 million > are living with HIV · New and infections declining or stable most racial · are in ethnic groups. New increased 30% American Indian and · infections > in Alaska Native populations. 2 Types of HIV : - · * HIV-1 HIV in US Western Central and South America (most commons cause Europe : of - , , * HIV-2 : -cause of South and India Cless common/less HIV in Africa infectious) made disease- Effective antiviral therapies have AIDS chronic · a · Blood-borne pathogen (blood , vaginal fluid , semen , breast milk) · Routes transmission blood blood products IV drug use, sexual activity, of or - , maternal-child transmission before or during birth. => HIV : Mechanism of Enjury · Retrovirus (RNA) Genetic information is in the form of RNA - Cstores genetic material on single-stranded RNA rather than usual double-stranded DNA) - contains reverse transcriptase to convert RNA and creates a double stranded DNA version of the virus. Integrase inserts new DNA into infected cell's genetic material - ↳ May be dormant no problems develop : ↳ May activate many problems develop : - New DNA becomes and accelerates part cell's genetic material - of and apoptosis shedding of infectious HIV => HIV Structure gp120 protein binds to the CD4 molecule found primarily surface of helper T cells. · on (Typically CD4 : CD8 ratio) + Destroys CD4 Th cells 800 to 1000 cells/mm3 Reverses - , , Co-receptors · - CXCR4 and CCR5 (strains can be selective for these receptors , influences the tropism cells). of the target Clinical => manifestations of HIV Serologically negative serologically positive but asymptomatic early - , , Stages of HIV or AIDS , kindow period infectious but asymptomatic :. - - Th cells 200 cells/mm3 diagnostic for AIDS - Fatigue , headache muscle aches fever, , may be asymptomatic years - for made => Diagnosis of AIDS is in association with variousclinical conditions and lab tests : Atypical opportunistic infections and - or cancer Presence antibodies of against HIV - - CD4 + T-cell numbers are at or below 200 cells/mL (dependsa => Phases of HIV Disease => Prevention HIV of not made vaccines so very effective : progress is being - far - reduce risk behaviors. => Research on HIV Fusion inhibitors (interferes with HN and CD4+ cells fusion of - - Integrase inhibitors (worked in monkeys to slow disease progression ; - undergone clinical trials) have Entrance inhibitors (co-receptor binding inhibition) - Uses · monodonal antibodies to inhibit binding to co-receptors.

Use Quizgecko on...
Browser
Browser